Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Cross

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 3, 2010
Reply: Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus-infected liver transplant recipientsTimothy J S Cross, Andrew K Burroughs, Phillip M Harrison
American Journal of Hematology|February 24, 2006
Imatinib mesylate as a cause of acute liver failureTimothy J S Cross, Catherine Bagot, Bernard Portmann, et al.
Clinical Transplantation|April 27, 2011
Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrenceTimothy J S Cross, Dinesh Jothimani, Michael A Heneghan, et al.
Hepatology (Baltimore, Md.)|September 15, 2009
Limitations of the algorithm for the SAFE biopsy: a noninvasive fibrosis measure in chronic hepatitis CMohammed Rashid, Jonathon D Mitchell, Matthew E Cramp, et al.
Journal of Gastroenterology and Hepatology|November 16, 2010
Treatment of autoimmune hepatitis: a review of current and evolving therapiesDinesh Jothimani, Matthew E Cramp, Jonathon D Mitchell, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 17, 2010
The importance of steatosis in chronic hepatitis C infection and its management: A reviewTimothy J S Cross, Mohammed M Rashid, Philip A Berry, et al.
Journal of Medical Virology|April 27, 2010
Do steatosis and steatohepatitis impact on sustained virological response (SVR) rates in patients receiving pegylated interferon and ribavirin for chronic hepatitis C infection?T J S Cross, A Quaglia, J Nolan, et al.
Journal of Viral Hepatitis|February 10, 2009
The impact of hepatic steatosis on the natural history of chronic hepatitis C infectionT J S Cross, A Quaglia, S Hughes, et al.
Gastrointestinal Endoscopy|June 20, 2008
A removable covered self-expanding metal stent for the management of Sengstaken-Blakemore tube-induced esophageal tear and variceal hemorrhageWolf-Rudiger Matull, Timothy J S Cross, Dominic Yu, et al.
Alimentary Pharmacology & Therapeutics|October 22, 2013
The liver to abdominal area ratio (LAAR): a novel imaging score for prognostication in cirrhosisT J S Cross, M Joseph, R A M Fernando, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 3, 2010
Reply: Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus-infected liver transplant recipientsTimothy J S Cross, Andrew K Burroughs, Phillip M Harrison
American Journal of Hematology|February 24, 2006
Imatinib mesylate as a cause of acute liver failureTimothy J S Cross, Catherine Bagot, Bernard Portmann, et al.
Clinical Transplantation|April 27, 2011
Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrenceTimothy J S Cross, Dinesh Jothimani, Michael A Heneghan, et al.
Hepatology (Baltimore, Md.)|September 15, 2009
Limitations of the algorithm for the SAFE biopsy: a noninvasive fibrosis measure in chronic hepatitis CMohammed Rashid, Jonathon D Mitchell, Matthew E Cramp, et al.
Journal of Gastroenterology and Hepatology|November 16, 2010
Treatment of autoimmune hepatitis: a review of current and evolving therapiesDinesh Jothimani, Matthew E Cramp, Jonathon D Mitchell, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 17, 2010
The importance of steatosis in chronic hepatitis C infection and its management: A reviewTimothy J S Cross, Mohammed M Rashid, Philip A Berry, et al.
Journal of Medical Virology|April 27, 2010
Do steatosis and steatohepatitis impact on sustained virological response (SVR) rates in patients receiving pegylated interferon and ribavirin for chronic hepatitis C infection?T J S Cross, A Quaglia, J Nolan, et al.
Journal of Viral Hepatitis|February 10, 2009
The impact of hepatic steatosis on the natural history of chronic hepatitis C infectionT J S Cross, A Quaglia, S Hughes, et al.
Gastrointestinal Endoscopy|June 20, 2008
A removable covered self-expanding metal stent for the management of Sengstaken-Blakemore tube-induced esophageal tear and variceal hemorrhageWolf-Rudiger Matull, Timothy J S Cross, Dominic Yu, et al.
Alimentary Pharmacology & Therapeutics|October 22, 2013
The liver to abdominal area ratio (LAAR): a novel imaging score for prognostication in cirrhosisT J S Cross, M Joseph, R A M Fernando, et al.
Pageof 7